期刊文献+

反相高效液相色谱法测定人血清中多索茶碱浓度 被引量:5

Determination of Doxofylline Concentration in Human Plasma by RP-HPLC
暂未订购
导出
摘要 目的 建立反相高效液相色谱法测定人血清中多索茶碱浓度。方法  采用高效液相色谱法 ,苯巴比妥为内标 ,YWG-C1 8色谱柱 ,甲醇∶水 ( 3 0∶ 70 )为流动相 ,流速 1.0 ml·min- 1 ,柱温 3 5℃ ,检测波长 2 10 nm。 结果  多索茶碱在 0 .40~ 2 4.0 0 μg· m L- 1浓度范围内呈良好线性关系 ,r=0 .9997;血清最低检测限为 10 0 mg·m L- 1 ;平均回收率为 98.71%;日内和日间 RSD分别为 2 .2 9%和 3 .3 7%。 结论  本法灵敏简便、准确可靠 。 OBJECTIVE To establish a method of RP HPLC for the determination of doxofylline concentration in human plasma.METHODS An RP HPLC was carried out on YWG C 18 .Phenobarbital was used as the internal standard.The mobile phase was composed of methanol water(30∶70),the flow rate was 1 0ml·min -1 the column temperation was set at 35℃,the detecting wavelength was set at 210 nm.RESULTS The assay was shown to produce linear calibration curves over the range from0 40μg·ml -1 to 24 00μg·mL -1 for doxofylling,r=0 9997,and the lowest plasma limitation was 100mg·mL -1 .The average recovery was 98 71%and the coefficients of variation within a day and between days did not exceed2 29%,3 37%.CONCLUSION The method is found to be sensitive simple convenient and accurate for the determination of doxofylline concentration in human plasma and clinical pharmacokinetic study.
出处 《海峡药学》 2003年第4期28-30,共3页 Strait Pharmaceutical Journal
关键词 多索茶碱 反相-高效液相色谱 血药浓度监测 Doxofylline RP HPLC Therapeutic drug monitoring
  • 相关文献

参考文献11

二级参考文献20

  • 1陈继慈.反相高效液相色谱法测定人血清中茶碱、咖啡因浓度[J].中国医院药学杂志,1994,14(3):122-124. 被引量:10
  • 2郭辉,徐小莹,何丽一,黄俊华.多索茶碱在大鼠体内的药代动力学[J].药学学报,1997,32(2):81-84. 被引量:8
  • 3叶丽卡,中国临床药学杂志,1991年,7卷,4期,221页
  • 4Lagana A, Bizzarri M, Marino A, et al.Solid phase extraction and hige performance liquid chromatographic determination of doxophylline in plasma[J].Biomed Chromatogr,1990, 4(5):205.
  • 5Tagliaro F, Borizzi R, Frigerio A, et al.Non-extraction HPLC method simultaneous measurement of dyphylline and doxophylline in serum[J].Clin chem, 1990, 36(1):113.
  • 6 Franzone JS,Cirillo R, Biffignandi P. Doxofylline exerts a prophylactic effect againstbronchocostriction and pleurisy induced by PAF[J]. Eur J Pharmacol, 1989, 165(2)∶269
  • 7 Grossi E, Franzone JS, Biffignandi P,et al. Effect of doxofylline, a novelbronchodilator, and theophylline in reversible COPD patients[J]. J Clin Pharm Ther,1988, 45∶168 [3] Lagana A, Bizzarri M, Marino A,et al. Soild phase extration and highperformance liquid chromatographic determination of doxophylline in plasma[J]. BiomedChromatogr, 1990, 4(5)∶205
  • 8 Bolona E,Lagana A,Terracino D,et al. Oral and intravenous pharmacokineticprofiles of doxofylline in patients with chronic bronchitis[J]. J Int MedRes,1990,18(4)∶282
  • 9 Franzone JS, Cravanzola C, Masera F. Preliminary studies of theabsorption,distribution and excretion of 2-(7'-thephyllinoemethyl)-1,3-dioxolane in rat[J].Farmaco Sci, 1981, 36 (3)∶220
  • 10 Stavaric B. Methylxanthines: toxicity to humans. 1: Theophylline[J]. JChem Toxicol, 1988, 26∶541

共引文献52

同被引文献47

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部